 |
Contact Us Sitemap |
 |
|
 |
|
|
Latest Press Releases 2005 Press Releases 2004 Press Releases 2003 Press Releases 2002 Press Releases 2001 Press Releases 2004 Annual Report Fact Sheet Contact |
 |
December 2005
December-21-2005
SciClone Reports Results From ZADAXIN Proof-of-Concept Liver Cancer Trial
December-14-2005
SciClone and Sigma-Tau Report Promising Interim Phase 2 Results in Advanced-Stage Malignant Melanoma Trial
December-14-2005
SciClone Reports Results From First ZADAXIN Phase 3 Hepatitis C Trial
December-13-2005
SciClone to Host a Conference Call December 14, 2005 to Discuss ZADAXIN Phase 3 Hepatitis C Results and Interim Phase 2 Malignant Melanoma Data
November 2005
November-16-2005
SciClone Announces Data Presentations at AASLD Regarding ZADAXIN's Activity in Hepatitis B
November-03-2005
SciClone to Present at Rodman and Renshaw Techvest Healthcare Conference
November-01-2005
SciClone Reports Third Quarter 2005 Results
October 2005
October-13-2005
SciClone to Report Third Quarter 2005 Results on November 1, 2005
October-13-2005
SciClone Pharmaceuticals to Present at Biotechnology Industry Organization (BIO) Investor Forum
October-10-2005
SciClone Names Israel Rios, M.D. as Chief Medical Officer
September 2005
September-27-2005
SciClone to Report Top-Line Data From First U.S. Hepatitis C Phase 3 Trial by Mid-December 2005
September-19-2005
SciClone Pharmaceuticals to Present at UBS Global Life Sciences Conference
August 2005
August-08-2005
SciClone Reports Second Quarter 2005 Results
July 2005
July-25-2005
SciClone Presents Preclinical Data Demonstrating SCV-07's Activity in Human Papillomavirus and Lassa Fever Models
July-13-2005
SciClone to Report Second Quarter 2005 Results on August 8, 2005
June 2005
June-23-2005
SciClone Files IND Application for SCV-07
June-21-2005
SciClone Announces Zadaxin Hepatitis C Triple Therapy Poster Presentation
June-09-2005
SciClone Comments on Recent Trading Activity
May 2005
May-05-2005
SciClone Reports First Quarter 2005 Results
April 2005
April-28-2005
SciClone Names Ira D. Lawrence, M.D. to Serve as President and Chief Executive Officer
April-07-2005
SciClone to Report First Quarter 2005 Results on May 5, 2005
April-04-2005
SciClone Announces Presentation of ZADAXIN Mechanism of Action at American Association of Immunologists Conference
February 2005
February-23-2005
SciClone Reports Results for Fourth Quarter and Full Year 2004
February-18-2005
SciClone Reports Management Change
February-01-2005
SciClone Announces the Appointment of Dean S. Woodman to Chairman of the Board of Directors
January 2005
January-31-2005
SciClone to Report Fourth Quarter 2004 Results on February 23, 2005
Site design by Formative